{"id": "375183", "url": "https://fevir.net/resources/EvidenceVariable/375183", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"], "versionId": "9", "lastUpdated": "2025-11-20T13:53:03.473Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[No data.]</p></div>", "status": "empty"}, "title": "GroupAssignment: Quadpill vs. Candesartan", "actual": true, "author": [{"name": "Brian S. Alper, MD, MSPH"}], "citeAs": "GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375183. Revised 2025-11-20. Available at: https://fevir.net/resources/EvidenceVariable/375183. Computable resource at: https://fevir.net/resources/EvidenceVariable/375183#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "category": [{"name": "Quadpill once daily", "valueReference": {"type": "Group", "display": "QUARTET USA Trial Quadpill group", "reference": "Group/375175"}}, {"name": "Candesartan 8 mg once daily", "valueReference": {"type": "Group", "display": "QUARTET USA Trial Control Group", "reference": "Group/375182"}}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "definition": {"concept": {"coding": [{"code": "defined-in-handling-and-category", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Defined in handling and category elements"}]}}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "375183", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "useContext": [{"code": {"code": "evidence-communication", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"code": "GroupAssignment", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "GroupAssignment"}]}}], "description": "Example of GroupAssignment Profile", "resourceType": "EvidenceVariable", "name": "GroupAssignment_Quadpill_vs_Candesartan", "handling": "dichotomous"}